Viatris (VTRS) Stock
Viatris (VTRS) closed at $20.82 on Nov 13, 2026; its Tenet Score is 39 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $20.82
- Nov 13, 2026
- Market cap
- $23.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 10.15 – 21.20
- low → high
- Tenet Score
- 39/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Viatris Inc scores 39/100. Weak. Financial health is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Graham Defensive
- ~ Income & Dividend Safety
- ~ Dividend Growth
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active p…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Illumina IncILMN | 51 | $31.3B |
| Roivant Sciences LtdROIV | 42 | $28.6B |
| Insmed IncINSM | 33 | $26.6B |
| United Therapeutics CorpUTHR | 72 | $25.2B |
| Incyte Corp.INCY | 64 | $24.7B |
| Alnylam Pharmaceuticals IncALNY | 59 | $22.1B |
| Medpace Holdings IncMEDP | 57 | $18.3B |
| Exelixis IncEXEL | 71 | $17.1B |
| Ascendis Pharma A/SASND | 54 | $17.1B |
| Neurocrine Biosciences, Inc.NBIX | 59 | $16.9B |
Compare Viatris with
Common questions
What sector and industry is Viatris in?
Viatris is in the Healthcare sector and the Drugs industry.
What is Viatris' Tenet Score?
Viatris' Tenet Score is 39 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




